Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 3/20 | 0.42 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | PLEC | Q15149 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | DAO | P14920 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tromethamine SCHEMBL23214395 | 0.88 | GABRA1 (0.37) | GABRA1GABRB2MAPTL3MBTL1NPSR1 | |
| SCHEMBL28355570 | 0.85 | PTGS2 (0.45) | THRBALOX5PTGS2PPARA | |
| SCHEMBL30803771 | 0.85 | GABRA1 (0.40) | GABRA1GABRB2MAPTL3MBTL1NPSR1 | |
| SCHEMBL30523275 | 0.85 | GABRA1 (0.40) | GABRA1GABRB2MAPTL3MBTL1NPSR1 | |
| SCHEMBL500199 | 0.85 | GABRA1 (0.40) | GABRA1GABRB2MAPTL3MBTL1NPSR1 | |
| SCHEMBL444140 | 0.83 | NCEH1 (0.30) | GABRA1GABRB2 | |
| SCHEMBL9052967 | 0.82 | L3MBTL1 (0.48) | GABRA1GABRB2MAPTL3MBTL1NPSR1 | |
| SCHEMBL31357462 | 0.82 | L3MBTL1 (0.48) | GABRA1GABRB2MAPTL3MBTL1NPSR1 | |
| SCHEMBL5967670 | 0.81 | GABRA1 (0.57) | GABRA1GABRB2MAPTL3MBTL1NPSR1 | |
| SCHEMBL447215 | 0.80 | GABRA1 (0.35) | GABRA1GABRB2MAPTL3MBTL1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 363 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111293360-A | Electrolyte and lithium secondary battery comprising the same | 三星电子株式会社 | 2020-06-16 | — | — | CN | claimed |
| CN-122011026-A | Asymmetric bidentate phosphine ligand and synthesis method thereof | 淮北师范大学 | 2026-05-12 | — | — | CN | disclosed |
| WO-2026087408-A1 | PROCESS FOR PREPARING ALPHA DELTA DI-CARBONYL DERIVATIVES | FIRMENICH SA (CH) | 2026-04-30 | — | — | WO | disclosed |
| US-20250137091-A1 | PROCESSES FOR RECOVERING RHODIUM FROM HYDROFORMYLATION PROCESSES | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2025-05-01 | — | — | US | disclosed |
| US-12246310-B2 | Processes for recovery of rhodium from a hydroformylation process | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2025-03-11 | — | — | US | disclosed |
| EP-4054762-B1 | PROCESSES FOR RECOVERY OF RHODIUM FROM A HYDROFORMYLATION PROCESS | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2024-12-18 | — | — | EP | disclosed |
| EP-4450484-A1 | METHOD FOR PRODUCING ALDEHYDE, METHOD FOR PRODUCING ALCOHOL, AND CATALYST COMPOSITION | Mitsubishi Chemical Corporation (JP) | 2024-10-23 | — | — | EP | disclosed |
| EP-3710161-B1 | PROCESSES FOR RECOVERY OF RHODIUM FROM A HYDROFORMYLATION PROCESS | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2024-10-16 | — | — | EP | disclosed |
| EP-4442673-A1 | METHOD FOR PRODUCING ALDEHYDE | Mitsubishi Chemical Corporation (JP) | 2024-10-09 | — | — | EP | disclosed |
| US-20240327325-A1 | METHOD FOR PRODUCING ALDEHYDE, METHOD FOR PRODUCING ALCOHOL, AND CATALYST COMPOSITION | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-10-03 | — | — | US | disclosed |
| EP-0255794-A1 | Process for preparing an aromatic acid | RHONE-POULENC CHIMIE (FR) | 1988-02-10 | — | — | EP | disclosed |
| EP-0244329-A2 | Process for the preparation of aromatic aldehydes | RHONE-POULENC CHIMIE (FR) | 1987-11-04 | — | — | EP | disclosed |
| EP-0244328-A2 | Process for the preparation of aromatic aldehydes | RHONE-POULENC CHIMIE (FR) | 1987-11-04 | — | — | EP | disclosed |
| US-4689411-A | ANTIBIOTICS | OTSUKA KAGAKU YAKUHIN KABUSHIKI KAISHA (JP) | 1987-08-25 | — | — | US | disclosed |
| EP-0109606-B1 | PROCESS FOR THE FORMYLATION OF ARYL HALIDES | BAYER AG (DE) | 1986-01-22 | — | — | EP | disclosed |
| US-4536344-A | USING A PHOSPINE OR PHOSPHITE | BAYER AKTIENGESELLSCHAFT (DE) | 1985-08-20 | — | — | US | disclosed |
| US-4490559-A | SYNTHESIS GAS AND A GROUP VII COMPOUND CATALYST | SHELL OIL COMPANY (US) | 1984-12-25 | — | — | US | disclosed |
| EP-0109606-A1 | Process for the formylation of aryl halides | BAYER AG (DE) | 1984-05-30 | — | — | EP | disclosed |
| US-4447648-A | USING SYNTHESIS GAS AND A GROUP VIII COMPOUND | UNION CARBIDE CORPORATION (US) | 1984-05-08 | — | — | US | disclosed |
| US-4429165-A | TRIVALENT ORGANOPHOSPHORUS AND ORGANONITROGEN COMPOUNDS AS PROMOTERS | UNION CARBIDE CORPORATION (US) | 1984-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250137091-A1 | PROCESSES FOR RECOVERING RHODIUM FROM HYDROFORMYLATION PROCESSES | NUDT1, HIRA, HARS1 | GABRA1 4553/4885GABRB2 4351/4885MAPT 2262/4885 |
| US-20240327325-A1 | METHOD FOR PRODUCING ALDEHYDE, METHOD FOR PRODUCING ALCOHOL, AND CATALYST COMPOSITION | ADH1A, ADH1C, ADH5 | GABRA1 2043/4885GABRB2 1836/4885MAPT 439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.